Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIME-IVF study
2018-001683-37Phase 4Active
- Sponsor
- Rigshospitalet
- Start
- May 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propranolol, atenolol, bisoprolol, nadolol and metoprolol in ventricular fibrillation (VF) and unexplained cardiac arrest (UCA) (2 arms), sponsored by Rigshospitalet. Primary endpoints: First appropriate ICD therapy, Aborted shock or non-sustained ventricular fibrillation prompting medication change and 1 more. Started May 2018; status: active.
02
Drugs
propranololatenololbisoprololnadololmetoprolol
03
Conditions
ventricular fibrillation (VF)unexplained cardiac arrest (UCA)
Beyond the preview
Go deeper on 2018-001683-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001683-37.